Joycelynne Palmer

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE”.

Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Blood(2022)10.1182/blood.2022015423

N/A

3.0DataRank · unranked

121 citations

Hun Ju Lee, Joycelynne Palmer, Robert Chen, Ni‐Chun Tsai, Lu Chen +18 more

Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study

Blood Advances(2021)10.1182/bloodadvances.2021005035

N/A

1.4DataRank · unranked

45 citations

Ni‐Chun Tsai, Timothy W. Synold, Sally Mokhtari, Weimin Tsia, Joycelynne Palmer +14 more

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma

Blood Advances(2021)10.1182/bloodadvances.2021004981

N/A

0.733DataRank · unranked

13 citations

Joycelynne Palmer, Vikram Adhikarla, Dave Yamauchi, Erasmus Poku, James R. Bading +23 more

A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy

The Oncologist(2023)10.1093/oncolo/oyad036

N/A

0.434DataRank · unranked

17 citations

Oren Wei, Ni‐Chun Tsai, Joycelynne Palmer, Sumanta K. Pal, Yung Lyou +2 more

The impact of gender, age, race/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas

Supportive Care in Cancer(2021)10.1007/s00520-021-06241-6

N/A

0.385DataRank · unranked

12 citations

Arnab Chowdhury, Tracey Stiller, Joycelynne Palmer, Matthew Loscalzo, Estella Barrios +5 more

Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high‐risk relapsed/refractory Hodgkin lymphoma

HemaSphere(2025)10.1002/hem3.70126

N/A

0.330DataRank · unranked

8 citations

Joycelynne Palmer, Hun Ju Lee, Iris Isufi, Robert Chen, Ni‐Chun Tsai +13 more

Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2023.05.011

N/A

0.182DataRank · unranked

2 citations

Joycelynne Palmer, Nicole Tsai, Jennifer Simpson, James O’Hearn, Anthony S. Stein +10 more

Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma

Blood Advances(2024)10.1182/bloodadvances.2023012497

N/A

0.110DataRank · unranked

1 citations

Ni‐Chun Tsai, Joycelynne Palmer, Jennifer Simpson, Vikram Adhikarla, James R. Bading +20 more

A phase 1 trial of 8‐chloro‐adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics

Cancer(2023)10.1002/cncr.35077

N/A

0DataRank · unranked

5 citations

Lisa S. Chen, Joycelynne Palmer, Jianying Zhang, Timothy W. Synold, Ralf Buettner +8 more

Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia

Blood Cancer Journal(2023)10.1038/s41408-023-00881-z

N/A

0DataRank · unranked

4 citations

Samer K. Khaled, Yan Wang, Xiuli Wang, Joycelynne Palmer, Mary C. Clark +6 more

Leflunomide Confers Rapid Recovery from COVID-19 and is Coupled with Temporal Immunologic Changes

Journal of Immunological Sciences(2023)10.29245/2578-3009/2023/1.1241

N/A

0DataRank · unranked

1 citations

James F. Sanchez, Joycelynne Palmer, Timothy W. Synold, Flavia Chiuppesi, Sandra P. Thomas +11 more

A phase 1 trial of umbilical cord blood–derived tumor-reactive PD-L1+ natural killer cells engineered to express soluble IL-15 (TRACK-NK) in patients with non–small-cell lung cancer (NSCLC) refractory to PD-1/PD-L1 inhibitors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps2665

N/A

0DataRank · unranked

4 citations

Stephen J. Forman, Joycelynne Palmer, Timothy W. Synold, Lei Tian, Ting Lu +14 more

Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.013

N/A

0DataRank · unranked

14 citations

Haoyue Shan, Dongyun Yang, Mary C. Clark, Monzr M. Al Malki, Ahmed Aribi +17 more

Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B‐Cell Lymphoma

American Journal of Hematology(2024)10.1002/ajh.27548

N/A

0DataRank · unranked

13 citations

Reid W. Merryman, Yan Wang, Charles Gaulin, Evandro D. Bezerra, Timothy Voorhees +16 more

PDXpower: A Power Analysis Tool for Experimental Design in Pre-clinical Xenograft Studies for Uncensored and Censored Outcomes

arXiv (Cornell University)(2024)10.48550/arxiv.2404.08927

N/A

0DataRank · unranked

0 citations

Donatello Telesca, Harley I. Kornblum, David A. Nathanson, Frank Pajonk, Elvis Han Cui +3 more

Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.05.017

N/A

0DataRank · unranked

7 citations

Joycelynne Palmer, Timothy W. Synold, Behrouz Salehian, Michael Rosenzweig, James F. Sanchez +12 more

PDXpower: A Power Analysis Tool for Experimental Design in Pre-clinical Xenograft Studies for Uncensored and Censored Outcomes

The New England Journal of Statistics in Data Science(2025)10.51387/25-nejsds76

N/A

0DataRank · unranked

0 citations

Donatello Telesca, Harley I. Kornblum, David A. Nathanson, Frank Pajonk, Elvis Han Cui +3 more

A Phase II Trial of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2019.12.752

N/A

0DataRank · unranked

2 citations

Ni‐Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Thai M. Cao, Haris Ali +13 more

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.03.029

N/A

0DataRank · unranked

42 citations

Carrie L. Kitko, Stephanie J. Lee, Paul A. Carpenter, Geoff D.E. Cuvelier, Shernan G. Holtan +25 more

Cytokine gene polymorphisms are associated with response to blinatumomab in B‐cell acute lymphoblastic leukemia

European Journal Of Haematology(2021)10.1111/ejh.13622

N/A

0DataRank · unranked

5 citations

Ibrahim Aldoss, Dongyun Yang, Sally Mokhtari, Ketevan Gendzekhadze, Samer K. Khaled +11 more

Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastoma

Neuro-Oncology(2022)10.1093/neuonc/noac024

N/A

0DataRank · unranked

144 citations

Analiz Rodriguez, Joycelynne Palmer, Julie R. Ostberg, Araceli Naranjo, Jamie R. Wagner +18 more

Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2038

N/A

0DataRank · unranked

57 citations

Samer K. Khaled, Xiuli Wang, Joycelynne Palmer, Yan Wang, Jamie R. Wagner +17 more

Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in Remission

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.03.025

N/A

0DataRank · unranked

13 citations

Monzr M. Al Malki, Dongyun Yang, Joycelynne Palmer, Ni‐Chun Tsai, Ibrahim Aldoss +18 more

Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma

American Journal of Hematology(2023)10.1002/ajh.27069

N/A

0DataRank · unranked

34 citations

Stacy Pak, Matthew Mei, Yan Wang, Leslie Popplewell, John H. Baird +13 more